Baird lowered the firm’s price target on Emerson (EMR) to $143 from $146 and keeps a Neutral rating on the shares. The firm updated its model following results whic introduced moving pieces to its 2026 guidance but the underlying dynamics are stable and healthy.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMR: